Judicial Panel on Multidistrict Litigation Issues Order on Allergan Biocell Textured Breast Implant Products
June 04, 2021
June 04, 2021
WASHINGTON, June 4 -- The Judicial Panel on Multidistrict Litigation issued the following order (MDL No. 2921):
IN RE: ALLERGAN BIOCELL TEXTURED BREAST IMPLANT PRODUCTS LIABILITY LITIGATION
TRANSFER ORDER
Before the Panel: Defendant Allergan USA, Inc., moves under 28 U.S.C. Sec. 1407(c) for transfer of the action listed on Schedule A (Calais) to the District of New Jersey for inclusion in MDL No. 2921. Plaintiff did not respond to the motion and, therefore, . . .
IN RE: ALLERGAN BIOCELL TEXTURED BREAST IMPLANT PRODUCTS LIABILITY LITIGATION
TRANSFER ORDER
Before the Panel: Defendant Allergan USA, Inc., moves under 28 U.S.C. Sec. 1407(c) for transfer of the action listed on Schedule A (Calais) to the District of New Jersey for inclusion in MDL No. 2921. Plaintiff did not respond to the motion and, therefore, . . .